{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:11:03Z","timestamp":1794352263079,"version":"4.9.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08452-z","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:28:52Z","timestamp":1783477732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Minimally invasive circulating MicroRNA signatures for breast cancer detection and neoadjuvant therapy response prediction in a multicenter MENA cohort"],"prefix":"10.1186","volume":"24","author":[{"given":"Radhakrishnan","family":"Vishnubalaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikmat","family":"Abdel-Razeq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salahddin A.","family":"Gehani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher","family":"Sughayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hibah","family":"Shaath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remy","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neyla Al","family":"Akl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artefaa","family":"Al-Shamari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamila El","family":"Mabrok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulsoom","family":"Junejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renad Hamdan","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelilah","family":"Arredouani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Decock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Albagha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1546-1091","authenticated-orcid":false,"given":"Nehad M.","family":"Alajez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"7","key":"8452_CR1","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho AM, Laversanne M, Ferlay J, Colombet M, Pi\u00f1eros M, Znaor A, Parkin DM, Soerjomataram I, Bray F. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Intl J Cancer. 2025;156(7):1336\u201346. https:\/\/doi.org\/10.1002\/ijc.35278.","journal-title":"Intl J Cancer"},{"key":"8452_CR2","doi-asserted-by":"publisher","unstructured":"Chouchane L, Boussen H, Sastry KSR. Breast cancer in Arab populations: molecular characteristics and disease management implications. The Lancet Oncol. 2013;14(10):e417\u201324. https:\/\/doi.org\/10.1016\/S1470-2045(13)70165-7.","DOI":"10.1016\/S1470-2045(13)70165-7"},{"issue":"12","key":"8452_CR3","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1002\/ijc.35325","volume":"156","author":"M Zahwe","year":"2025","unstructured":"Zahwe M, Bendahhou K, Eser S, Mukherji D, Fouad H, Fadhil I, et al. Current and future burden of female breast cancer in the Middle East and North Africa region using estimates from GLOBOCAN 2022. Intl J Cancer. 2025;156(12):2320\u201329. https:\/\/doi.org\/10.1002\/ijc.35325.","journal-title":"Intl J Cancer"},{"issue":"4","key":"8452_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ccell.2020.03.012","volume":"37","author":"E Kilgour","year":"2020","unstructured":"Kilgour E, Rothwell DG, Brady G, Dive C. Liquid biopsy-based biomarkers of treatment response and resistance. Cancer Cell. 2020;37(4):485\u201395. https:\/\/doi.org\/10.1016\/j.ccell.2020.03.012.","journal-title":"Cancer Cell"},{"issue":"10","key":"8452_CR5","doi-asserted-by":"publisher","first-page":"101198","DOI":"10.1016\/j.xcrm.2023.101198","volume":"4","author":"SM Batool","year":"2023","unstructured":"Batool SM, Yekula A, Khanna P, Hsia T, Gamblin AS, Ekanayake E, et al. The liquid biopsy consortium: challenges and opportunities for early cancer detection and monitoring. Cell Rep. Med. 2023;4(10):101198. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101198.","journal-title":"Cell Rep. Med"},{"issue":"6","key":"8452_CR6","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1158\/0008-5472.CAN-10-2754","volume":"71","author":"NM Alajez","year":"2011","unstructured":"Alajez NM, Lenarduzzi M, Ito E, Hui ABY, Shi W, Bruce J, et al. MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res. 2011;71(6):2381\u201391. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2754.","journal-title":"Cancer Res"},{"issue":"4","key":"8452_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.tig.2021.10.002","volume":"38","author":"MP Dragomir","year":"2022","unstructured":"Dragomir MP, Knutsen E, Calin GA. Classical and noncanonical functions of miRNAs in cancers. Trends Genet. 2022;38(4):379\u201394. https:\/\/doi.org\/10.1016\/j.tig.2021.10.002.","journal-title":"Trends Genet"},{"key":"8452_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcancer.2019.11.006","volume":"65","author":"R Vishnubalaji","year":"2020","unstructured":"Vishnubalaji R, Shaath H, Elango R, Alajez NM. Noncoding RNAs as potential mediators of resistance to cancer immunotherapy. Semin Cancer Biol. 2020;65:65\u201379. https:\/\/doi.org\/10.1016\/j.semcancer.2019.11.006.","journal-title":"Semin Cancer Biol"},{"key":"8452_CR9","doi-asserted-by":"publisher","unstructured":"Hamam R, Hamam D, Alsaleh KA, Kassem M, Zaher W, Alfayez M, et al. Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers. Cell Death Dis. 2017;8(9):e 3045. https:\/\/doi.org\/10.1038\/cddis.2017.440.","DOI":"10.1038\/cddis.2017.440"},{"issue":"3","key":"8452_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41416-021-01593-6","volume":"126","author":"R Zou","year":"2022","unstructured":"Zou R, Loke SY, Tang YC, Too H-P, Zhou L, Lee ASG, et al. Development and validation of a circulating microRNA panel for the early detection of breast cancer. Br J Cancer. 2022;126(3):472\u201381. https:\/\/doi.org\/10.1038\/s41416-021-01593-6.","journal-title":"Br J Cancer"},{"issue":"3","key":"8452_CR11","doi-asserted-by":"publisher","first-page":"102621","DOI":"10.1016\/j.omtn.2025.102621","volume":"36","author":"BN Borsos","year":"2025","unstructured":"Borsos BN, P\u00e1hi ZG, Pankotai T. Pankotai T: exploring potent miRNA combinations for detecting early-stage breast cancer. Mol Ther Nucleic Acids. 2025;36(3):102621. https:\/\/doi.org\/10.1016\/j.omtn.2025.102621.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"8452_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10549-022-06642-z","volume":"194","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Zhang H, Yu J, Xu L, Pang X, Xiang Q, et al. Cui Y: miRNAs as therapeutic predictors and prognostic biomarkers of neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2022;194(3):483\u2013505. https:\/\/doi.org\/10.1007\/s10549-022-06642-z.","journal-title":"Breast Cancer Res Treat"},{"key":"8452_CR13","doi-asserted-by":"publisher","unstructured":"Sathipati SY, Tsai M-J, Aimalla N, Moat L, Shukla SK, Allaire P, et al. An evolutionary learning-based method for identifying a circulating miRNA signature for breast cancer diagnosis prediction. NAR Genomics Bioinf. 2024;6(1):lqae022. https:\/\/doi.org\/10.1093\/nargab\/lqae022.","DOI":"10.1093\/nargab\/lqae022"},{"issue":"1","key":"8452_CR14","doi-asserted-by":"publisher","first-page":"14456","DOI":"10.1038\/s41598-021-93531-y","volume":"11","author":"H Shaath","year":"2021","unstructured":"Shaath H, Toor SM, Nada MA, Elkord E, Alajez NM. Integrated whole transcriptome and small RNA analysis revealed multiple regulatory networks in colorectal cancer. Sci Rep. 2021;11(1):14456. https:\/\/doi.org\/10.1038\/s41598-021-93531-y.","journal-title":"Sci Rep"},{"issue":"1","key":"8452_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijms24010108","volume":"24","author":"SM Toor","year":"2022","unstructured":"Toor SM, Aldous EK, Parray A, Akhtar N, Al-Sarraj Y, Abdelalim EM, et al. Circulating MicroRNA profiling identifies distinct MicroRNA signatures in acute Ischemic stroke and transient Ischemic attack patients. IJMS. 2022;24(1):24. https:\/\/doi.org\/10.3390\/ijms24010108.","journal-title":"IJMS"},{"key":"8452_CR16","doi-asserted-by":"publisher","first-page":"1024790","DOI":"10.3389\/fcvm.2022.1024790","volume":"9","author":"SM Toor","year":"2022","unstructured":"Toor SM, Aldous EK, Parray A, Akhtar N, Al-Sarraj Y, Abdelalim EM, et al. Identification of distinct circulating microRNAs in acute ischemic stroke patients with type 2 diabetes mellitus. Front. Cardiovasc. Med. 2022;9:1024790. https:\/\/doi.org\/10.3389\/fcvm.2022.1024790.","journal-title":"Front. Cardiovasc. Med"},{"issue":"6","key":"8452_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijms23063387","volume":"23","author":"EK Aldous","year":"2022","unstructured":"Aldous EK, Toor SM, Parray A, Al-Sarraj Y, Diboun I, Abdelalim EM, et al. Identification of novel circulating miRNAs in patients with acute Ischemic stroke. IJMS. 2022;23(6):23. https:\/\/doi.org\/10.3390\/ijms23063387.","journal-title":"IJMS"},{"issue":"7","key":"8452_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41419-023-05908-8","volume":"14","author":"R Elango","year":"2023","unstructured":"Elango R, Rashid S, Vishnubalaji R, Al-Sarraf R, Akhtar M, Ouararhni K, et al. Transcriptome profiling and network enrichment analyses identify subtype-specific therapeutic gene targets for breast cancer and their microRNA regulatory networks. Cell Death Dis. 2023;14(7):415. https:\/\/doi.org\/10.1038\/s41419-023-05908-8.","journal-title":"Cell Death Dis"},{"issue":"8","key":"8452_CR19","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1038\/s41591-025-03730-7","volume":"31","author":"MV Joglekar","year":"2025","unstructured":"Joglekar MV, Wong WKM, Kunte PS, Hardikar HP, Kulkarni RA, Ahmed I, et al. A microRNA-based dynamic risk score for type 1 diabetes. Nat Med. 2025;31(8):2622\u201331. https:\/\/doi.org\/10.1038\/s41591-025-03730-7.","journal-title":"Nat Med"},{"issue":"1","key":"8452_CR20","doi-asserted-by":"publisher","first-page":"25997","DOI":"10.1038\/srep25997","volume":"6","author":"R Hamam","year":"2016","unstructured":"Hamam R, Ali AM, Alsaleh KA, Kassem M, Alfayez M, Aldahmash A, et al. Alajez NM: microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection. Sci Rep. 2016;6(1):25997. https:\/\/doi.org\/10.1038\/srep25997.","journal-title":"Sci Rep"},{"issue":"10","key":"8452_CR21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41416-025-02982-x","volume":"132","author":"T Colangelo","year":"2025","unstructured":"Colangelo T, Mazzarelli F, Cuttano R, Dama E, Melocchi V, Afanga MK, et al. Unveiling the origin and functions of diagnostic circulating microRNAs in lung cancer. Br J Cancer. 2025;132(10):947\u201356. https:\/\/doi.org\/10.1038\/s41416-025-02982-x.","journal-title":"Br J Cancer"},{"issue":"44","key":"8452_CR22","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1038\/onc.2009.241","volume":"28","author":"SK Leivonen","year":"2009","unstructured":"Leivonen SK, Makela R, Ostling P, Kohonen P, Haapa-Paananen S, Kleivi K, et al. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene. 2009;28(44):3926\u201336. https:\/\/doi.org\/10.1038\/onc.2009.241.","journal-title":"Oncogene"},{"issue":"1","key":"8452_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1476-4598-5-24","volume":"5","author":"MD Mattie","year":"2006","unstructured":"Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK, et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer. 2006;5(1):24. https:\/\/doi.org\/10.1186\/1476-4598-5-24.","journal-title":"Mol Cancer"},{"key":"8452_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bbacli.2015.03.003","volume":"3","author":"EA O\u2019Reilly","year":"2015","unstructured":"O\u2019Reilly EA, Gubbins L, Sharma S, Tully R, Guang MHZ, Weiner-Gorzel K, et al. The fate of chemoresistance in triple negative breast cancer (TNBC). BBA Clin. 2015;3:257\u201375. https:\/\/doi.org\/10.1016\/j.bbacli.2015.03.003.","journal-title":"BBA Clin"},{"issue":"1","key":"8452_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2017.99","volume":"18","author":"E Anastasiadou","year":"2018","unstructured":"Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5\u201318. https:\/\/doi.org\/10.1038\/nrc.2017.99.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"8452_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s40364-025-00856-1","volume":"13","author":"BY Abohalawa","year":"2025","unstructured":"Abohalawa BY, Eldous HG, Elango R, Vishnubalaji R, Rashid S, Ouararhni K, et al. Piwi-interacting RNA 775 (piR-775) predicts favorable prognosis and regulates cell cycle and DNA damage response pathways in breast cancer. Biomark Res. 2025;13(1):139. https:\/\/doi.org\/10.1186\/s40364-025-00856-1.","journal-title":"Biomark Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08452-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08452-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08452-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:03:18Z","timestamp":1790982198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08452-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8452"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08452-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and approved by the institutional review boards of Hamad Medical Corporation (HMC; MRC-01\u201319-248), King Hussein Cancer Center (KHCC; 20KHCC81), and Qatar Biomedical Research Institute (QBRI; QBRI-IRB 2021\u201303-082). All participants provided written informed consent prior to sample collection.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the manuscript and consent to its publication","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1233"}}